Alimera Sciences reported $14.6M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 14583M 1045M
Aerie Pharmaceuticals AERI:US $ 33.31M 3.48M
Alimera Sciences ALIM:US $ 14.6M 2.71M
Applied Genetic Technologies AGTC:US $ 0M 0M
Bayer BAYN:GR € 12819M 1820M
Insmed INSM:US $ 65.22M 12.11M
Novartis NOVN:VX SF 13085M 271M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Roche Holding ROG:VX 16.44B 474M